BR9713087A - Composição farmacêutica estabilizada, utilização e processo para preparar a mesma, e, utilização de ácido metanossulfÈnico ou ácido clorìdrico - Google Patents

Composição farmacêutica estabilizada, utilização e processo para preparar a mesma, e, utilização de ácido metanossulfÈnico ou ácido clorìdrico

Info

Publication number
BR9713087A
BR9713087A BR9713087-7A BR9713087A BR9713087A BR 9713087 A BR9713087 A BR 9713087A BR 9713087 A BR9713087 A BR 9713087A BR 9713087 A BR9713087 A BR 9713087A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
acid
prepare
stabilized pharmaceutical
hydrochloric acid
Prior art date
Application number
BR9713087-7A
Other languages
English (en)
Portuguese (pt)
Inventor
Jean-Paul Bounine
Guillaume Conrath
Original Assignee
Rh Ne Poulenc Rorer S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rh Ne Poulenc Rorer S A filed Critical Rh Ne Poulenc Rorer S A
Publication of BR9713087A publication Critical patent/BR9713087A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9713087-7A 1996-11-19 1997-11-14 Composição farmacêutica estabilizada, utilização e processo para preparar a mesma, e, utilização de ácido metanossulfÈnico ou ácido clorìdrico BR9713087A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9614062A FR2755857B1 (fr) 1996-11-19 1996-11-19 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation
PCT/FR1997/002047 WO1998022107A1 (fr) 1996-11-19 1997-11-14 Compositions pharmaceutiques stabilisees, a base de quinupristine et de dalfopristine et leur preparation

Publications (1)

Publication Number Publication Date
BR9713087A true BR9713087A (pt) 2000-03-28

Family

ID=9497744

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9713087-7A BR9713087A (pt) 1996-11-19 1997-11-14 Composição farmacêutica estabilizada, utilização e processo para preparar a mesma, e, utilização de ácido metanossulfÈnico ou ácido clorìdrico

Country Status (45)

Country Link
US (1) US5994338A (de)
EP (1) EP0949923B1 (de)
JP (1) JP4278115B2 (de)
KR (1) KR100530836B1 (de)
CN (1) CN1146417C (de)
AP (1) AP998A (de)
AR (1) AR008695A1 (de)
AT (1) ATE223217T1 (de)
AU (1) AU740291B2 (de)
BG (1) BG63621B1 (de)
BR (1) BR9713087A (de)
CA (1) CA2271095C (de)
CO (1) CO4910113A1 (de)
CZ (1) CZ299913B6 (de)
DE (1) DE69715247T2 (de)
DK (1) DK0949923T3 (de)
DZ (1) DZ2349A1 (de)
EA (1) EA002025B1 (de)
EE (1) EE03668B1 (de)
ES (1) ES2179375T3 (de)
FR (1) FR2755857B1 (de)
HK (1) HK1022832A1 (de)
HR (1) HRP970615B1 (de)
HU (1) HUP9904327A3 (de)
IL (2) IL129607A0 (de)
IN (1) IN187038B (de)
JO (1) JO1992B1 (de)
MA (1) MA26448A1 (de)
MY (1) MY123805A (de)
NO (1) NO992399D0 (de)
NZ (1) NZ334949A (de)
OA (1) OA11047A (de)
PE (1) PE13999A1 (de)
PL (1) PL190164B1 (de)
PT (1) PT949923E (de)
RS (1) RS49608B (de)
SA (1) SA97180645B1 (de)
SK (1) SK284311B6 (de)
TN (1) TNSN97184A1 (de)
TR (1) TR199901096T2 (de)
TW (1) TW474816B (de)
UA (1) UA59376C2 (de)
UY (1) UY24780A1 (de)
WO (1) WO1998022107A1 (de)
ZA (1) ZA9710435B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2772272B1 (fr) * 1997-12-16 2000-01-14 Rhone Poulenc Rorer Sa Compositions pharmaceutiques a base de dalfopristine et de quinupristine et leur preparation
EP1115417B1 (de) * 1998-09-25 2006-04-05 Cubist Pharmaceuticals, Inc. Verwendung von daptomycin
CN100335122C (zh) * 1999-03-03 2007-09-05 伊莱利利公司 含有成胶束表面活性剂的棘白菌素药物制剂
TWI233805B (en) * 1999-07-01 2005-06-11 Fujisawa Pharmaceutical Co Stabilized pharmaceutical composition in lyophilized form as antifungal agent
US6119269A (en) * 1999-09-23 2000-09-19 Imler; Jack Fishing vest with removable storage container system
US6696412B1 (en) 2000-01-20 2004-02-24 Cubist Pharmaceuticals, Inc. High purity lipopeptides, Lipopeptide micelles and processes for preparing same
FR2812549B1 (fr) * 2000-08-03 2003-03-21 Aventis Pharma Sa Associations dalfopristine/quinupristine avec le cefpirome
US20060014674A1 (en) 2000-12-18 2006-01-19 Dennis Keith Methods for preparing purified lipopeptides

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549065B1 (fr) * 1983-07-13 1985-10-25 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2576022B1 (fr) * 1985-01-11 1987-09-11 Rhone Poulenc Sante Nouveaux derives de la pristinamycine ii b, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2599036B1 (fr) * 1986-05-22 1988-09-09 Rhone Poulenc Sante Nouveaux derives de synergistines, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
CZ174899A3 (cs) 1999-08-11
BG63621B1 (bg) 2002-07-31
CA2271095C (fr) 2004-08-03
NZ334949A (en) 2000-12-22
TNSN97184A1 (fr) 2005-03-15
AP998A (en) 2001-08-09
IN187038B (de) 2001-12-29
NO992399L (no) 1999-05-19
JP2001504475A (ja) 2001-04-03
YU22499A (sh) 2002-03-18
ES2179375T3 (es) 2003-01-16
HRP970615B1 (en) 2002-12-31
WO1998022107A1 (fr) 1998-05-28
CO4910113A1 (es) 2000-04-24
PE13999A1 (es) 1999-05-05
DK0949923T3 (da) 2002-12-23
EA002025B1 (ru) 2001-12-24
US5994338A (en) 1999-11-30
DE69715247T2 (de) 2003-04-30
HK1022832A1 (en) 2000-08-25
EE03668B1 (et) 2002-04-15
HUP9904327A3 (en) 2002-03-28
PT949923E (pt) 2003-01-31
EP0949923A1 (de) 1999-10-20
CN1146417C (zh) 2004-04-21
DE69715247D1 (de) 2002-10-10
CZ299913B6 (cs) 2008-12-29
SK66099A3 (en) 2000-01-18
EE9900127A (et) 1999-12-15
SK284311B6 (sk) 2005-01-03
OA11047A (fr) 2003-03-07
KR100530836B1 (ko) 2005-11-23
EA199900479A1 (ru) 2000-02-28
AU5125698A (en) 1998-06-10
PL190164B1 (pl) 2005-11-30
ZA9710435B (en) 1998-06-10
IL129607A0 (en) 2000-02-29
NO992399D0 (no) 1999-05-19
AU740291B2 (en) 2001-11-01
BG103412A (en) 2000-06-30
CN1233959A (zh) 1999-11-03
HUP9904327A2 (hu) 2000-06-28
TW474816B (en) 2002-02-01
TR199901096T2 (xx) 1999-07-21
CA2271095A1 (fr) 1998-05-28
SA97180645B1 (ar) 2005-12-12
UA59376C2 (uk) 2003-09-15
EP0949923B1 (de) 2002-09-04
KR20000053343A (ko) 2000-08-25
JP4278115B2 (ja) 2009-06-10
DZ2349A1 (fr) 2002-12-28
AR008695A1 (es) 2000-02-09
UY24780A1 (es) 2001-08-27
MA26448A1 (fr) 2004-12-20
JO1992B1 (en) 1999-05-15
RS49608B (sr) 2007-06-04
HRP970615A2 (en) 1998-08-31
MY123805A (en) 2006-06-30
ATE223217T1 (de) 2002-09-15
FR2755857A1 (fr) 1998-05-22
IL129607A (en) 2006-08-20
FR2755857B1 (fr) 1998-12-24

Similar Documents

Publication Publication Date Title
BR9810829B1 (pt) composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica.
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
MX9204268A (es) Una composicion para la liberacion prolongada y controlada de substancias medicamentosas y un proceso para preparar la misma.
MX9206851A (es) Sales organicas de n,n'-diacetil cistina, proceso para su preparacion y composicion farmaceutica que las contiene.
BR9807577A (pt) Método para prevenir e retardar o inìcio da doença de alzheimer e sua composição
BRPI0111639B8 (pt) uso de uma molécula de ácido oligodeoxinucléico imunoestimulatório e composição farmacêutica.
IT8621358A0 (it) Composizione farmaceutica adattivita' analgesica.
ES2140565T3 (es) Nuevos derivados de pirazina-carboxamida, su preparacion y su utilizacion en medicamentos.
PT95510A (pt) Processo de preparacao de pirimidina 4'-tionucleosidos e de composicoes farmaceuticas que os contem
DE3785684T2 (de) Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung.
BR0009524A (pt) Uso de um composto, e, composição farmacêutica ou veterinaria
BR9809492A (pt) Composição farmacêutica aquosa injetável, e, processo para a preparação da mesma
BR9507771A (pt) Processos para preparação de ácido 1-Butil-2-(2'-(2H-Tetratozol-5-IL)-Bifenil-4-Ilmetil(-1H-Indol-3-Carboxílico
BR9713087A (pt) Composição farmacêutica estabilizada, utilização e processo para preparar a mesma, e, utilização de ácido metanossulfÈnico ou ácido clorìdrico
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
NO922380D0 (no) Substituerte 4-fenyl-4-piperidinkarboksamider med baade lokal anestetisk og analgetisk effekt samt fremgangsmaater for deres fremstilling
BR0012169A (pt) Dihidrobenzodiazepinas e seu uso no tratamento de dislipidemia
DK0416678T3 (da) Topiske præparater indeholdende Defibrotid
BR9915436A (pt) Certas caprolactamas substituìdas, composições farmacêuticas contendo as mesmas e seu uso no tratamento de tumores
BR9712307A (pt) Pirazolinonas para o tratamento de potência enfraquecida
PT90127A (pt) Processo para a preparacao de composicoes farmaceuticas com accao analgesica que contem 4-aril-4-piperidino (ou pirrolidino ou hexa-hidroazepino)-carbinois ou os seus analogos heterociclicos
ES2072332T3 (es) Derivados de la dibenzo(1,5)dioxocin-5-ona, su uso en medicamentos y procedimiento para su fabricacion.
ATE120369T1 (de) Verwendung stabiler oxapenem-3-carbonsäuren zur herstellung beta-lactamase hemmender arzneimittel.
BR9810387A (pt) (s) 3, 4, 5-trimetoxibenzoato de 2-metilamino-2-fenil-n-butila, e sua aplicação para o tratamento de dor crÈnica
ES1004869Y (es) Atadura para la fijacion de sarmientos.

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFIRO O PRESENTE PEDIDO DE PATENTE DE ACORDO COM ART. 8O DA LPI.